• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECKMAN COULTER ACCESS CK-MB REAGENT; FLUOROMETRIC METHOD, CPK OR ISOENZYMES

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECKMAN COULTER ACCESS CK-MB REAGENT; FLUOROMETRIC METHOD, CPK OR ISOENZYMES Back to Search Results
Catalog Number 386371
Device Problem High Test Results (2457)
Patient Problem No Code Available (3191)
Event Date 09/10/2015
Event Type  Injury  
Manufacturer Narrative
The customer did not provide patient weight.A beckman coulter (bec) field service engineer (fse) was dispatched to assess instrument performance.The fse proactively performed preventative maintenance on the access 2 immunoassay system.The fse did not note any system malfunction that would have contributed to the reported event.The access ck-mb reagent pack was not returned for evaluation.In conclusion, the cause of the non-reproducible access accutni+3 and access ck-mb results cannot be determined with the available information.(b)(4).All mdrs associated with this report: mdr2122870-2015-00618; mdr2122870-2015-00619.
 
Event Description
The customer reported non-reproducible troponin i (access accutni+3) and creatine kinase-muscle brain isoform (access ck-mb) results for one (1) patient on the access 2 immunoassay system (serial number (b)(4)).The customer runs all access accutni+3 samples in duplicate.It was noted both of the initial access accutni+3 results were elevated, above the normal reference range of the assay.The customer repeat tested the samples on the same access 2 immunoassay system and obtained lower results, within the normal reference range of the assays.Mdr2122870-2015-00618 addresses the access accutni+3 results.Mdr2122870-2015-00619 addresses the access ck-mb results.The initial elevated results were reported outside the laboratory and the patient was admitted to the hospital.All system parameters including access accutni+3 and access ck-mb quality control (qc), access accutni+3 and access ck-mb calibrations and system check were within assay specifications and instrument specifications.Sample information such as collection device, centrifugation speed and time were not provided.No issues with sample integrity were reported by the customer.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ACCESS CK-MB REAGENT
Type of Device
FLUOROMETRIC METHOD, CPK OR ISOENZYMES
Manufacturer (Section D)
BECKMAN COULTER
1000 lake hazeltine drive
chaska MN 55318
Manufacturer (Section G)
BECKMAN COULTER
1000 lake hazeltine drive
chaska MN 55318
Manufacturer Contact
jeffery koll
1000lake hazektine drive
chaska, MN 55318
MDR Report Key5105312
MDR Text Key26824012
Report Number2122870-2015-00619
Device Sequence Number1
Product Code JHX
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K030012
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,user faci
Reporter Occupation Other Health Care Professional
Report Date 09/10/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date02/28/2016
Device Catalogue Number386371
Device Lot Number437908
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received Not provided
Initial Date FDA Received09/25/2015
Was Device Evaluated by Manufacturer? No
Date Device Manufactured04/01/2015
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Unknown
Patient Sequence Number1
Patient Outcome(s) Hospitalization;
Patient Age83 YR
-
-